Hurdle (Decision/Risk Analysis) Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.92M
- Investors
-
9
Hurdle (Decision/Risk Analysis) General Information
Description
Developer of a diagnostic platform designed to facilitate better care, operational optimization, and personalized health interventions. The company's platform utilizes artificial intelligence to analyze diagnostic data and offer personalized and accurate diagnostics, enabling healthcare providers to improve accuracy, efficiency, scalability, and patient care.
Contact Information
Website
www.hurdle.bioCorporate Office
- Bizspace Wimbledon
- 8 Lombard Road
- London SW19 3TZ
- England, United Kingdom
Corporate Office
- Bizspace Wimbledon
- 8 Lombard Road
- London SW19 3TZ
- England, United Kingdom
Hurdle (Decision/Risk Analysis) Timeline
Hurdle (Decision/Risk Analysis) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 26-Mar-2025 | $7.92M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 13-Sep-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 09-Jan-2019 | Completed | Generating Revenue | |||
| 2. Angel (individual) | $100K | Completed | Startup | |||
| 1. Accelerator/Incubator | 22-Dec-2017 | $100K | $100K | Completed | Startup |
Hurdle (Decision/Risk Analysis) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred Ordinary | ||||||||
| Series A Preferred Ordinary | ||||||||
| Seed 2 | 8,113 | $0.012847 | $170.67 | $170.67 | 1x | $170.67 | 3.97% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Hurdle (Decision/Risk Analysis) Comparisons
Industry
Financing
Details
Hurdle (Decision/Risk Analysis) Competitors (22)
One of Hurdle (Decision/Risk Analysis)’s 22 competitors is ixLayer, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ixLayer | Venture Capital-Backed | San Francisco, CA | ||||
| DarioHealth | Formerly VC-backed | New York, NY | ||||
| Cognoa | Venture Capital-Backed | Palo Alto, CA | ||||
| Blue Mesa Health | Private Equity-Backed | New York, NY | ||||
| MEMOTEXT | Accelerator/Incubator Backed | Bethesda, MD |
Hurdle (Decision/Risk Analysis) Patents
Hurdle (Decision/Risk Analysis) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201810897-D0 | Phenotype prediction | Inactive | 03-Jul-2018 | ||
| WO-2020008192-A2 | Phenotype prediction | Inactive | 03-Jul-2018 | ||
| WO-2020008192-A3 | Phenotype prediction | Inactive | 03-Jul-2018 | G16B20/00 |
Hurdle (Decision/Risk Analysis) Signals
Hurdle (Decision/Risk Analysis) Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Expedite Capital | Venture Capital | Minority | ||
| Samos Investments | Venture Capital | Minority | ||
| Cola Blanca Investments | Corporation | Minority | ||
| Outsized Ventures | Venture Capital | Minority | ||
| Start Capital | Venture Capital | Minority |
Hurdle (Decision/Risk Analysis) FAQs
-
When was Hurdle (Decision/Risk Analysis) founded?
Hurdle (Decision/Risk Analysis) was founded in 2017.
-
Where is Hurdle (Decision/Risk Analysis) headquartered?
Hurdle (Decision/Risk Analysis) is headquartered in London, United Kingdom.
-
What is the size of Hurdle (Decision/Risk Analysis)?
Hurdle (Decision/Risk Analysis) has 33 total employees.
-
What industry is Hurdle (Decision/Risk Analysis) in?
Hurdle (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.
-
Is Hurdle (Decision/Risk Analysis) a private or public company?
Hurdle (Decision/Risk Analysis) is a Private company.
-
What is the current valuation of Hurdle (Decision/Risk Analysis)?
The current valuation of Hurdle (Decision/Risk Analysis) is .
-
What is Hurdle (Decision/Risk Analysis)’s current revenue?
The current revenue for Hurdle (Decision/Risk Analysis) is .
-
How much funding has Hurdle (Decision/Risk Analysis) raised over time?
Hurdle (Decision/Risk Analysis) has raised $17.2M.
-
Who are Hurdle (Decision/Risk Analysis)’s investors?
Expedite Capital, Samos Investments, Cola Blanca Investments, Outsized Ventures, and Start Capital are 5 of 9 investors who have invested in Hurdle (Decision/Risk Analysis).
-
Who are Hurdle (Decision/Risk Analysis)’s competitors?
ixLayer, DarioHealth, Cognoa, Blue Mesa Health, and MEMOTEXT are some of the 22 competitors of Hurdle (Decision/Risk Analysis).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process